<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04146246</url>
  </required_header>
  <id_info>
    <org_study_id>CSPROJ00004001</org_study_id>
    <nct_id>NCT04146246</nct_id>
  </id_info>
  <brief_title>Comparative Evaluation of the FINDER Instrument and FINDER G6PD Cartridge in Adults and Neonates</brief_title>
  <official_title>Comparative Evaluation of the FINDERTM Instrument and FINDERTM G6PD Cartridge in Adults and Neonates</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Baebies, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Baebies, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      A prospective clinical study to compare the clinical performance of the FINDER™ Instrument&#xD;
      and the G6PD assay to an FDA cleared instrument/reagent combination in adult and neonate&#xD;
      populations.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A prospective clinical study to compare the clinical performance of the FINDER™ Instrument&#xD;
      and the G6PD assay to an FDA cleared instrument/reagent combination in adult and neonate&#xD;
      populations. Neonate and adult subjects will be recruited from 3 clinical sites. Neonate&#xD;
      samples will be collected as heel prick unless an in dwelling line is already in place at&#xD;
      which point a venous or arterial/umbilical sample will be collected. Adult samples will be&#xD;
      collected as venous/arterial samples and finger stick samples. Samples will be tested at the&#xD;
      point of care/near patient and in the clinical laboratory using the FINDER Instrument and&#xD;
      G6PD assay on a digital microfluidic platform. Samples will also be sent to a third party&#xD;
      CLIA laboratory for test using an FDA 510(k) cleared instrument/reagent combination for G6PD.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 11, 2019</start_date>
  <completion_date type="Actual">March 13, 2020</completion_date>
  <primary_completion_date type="Actual">March 13, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>G6PD enzymatic activity in adults and neonates</measure>
    <time_frame>Immediately following a blood draw.</time_frame>
    <description>G6PD enzymatic activity in the FINDER System for adults and neonates compared to the G6PD activity tested using a known FDA cleared assay/instrument combination</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Point of care/near patient results and clinical laboratory results</measure>
    <time_frame>Immediately following a blood draw.</time_frame>
    <description>Characterization of the performance of the FINDER device when used at a POC/near patient location and when used in a clinical laboratory location.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Arterial/venous whole blood results and tissue capillary test results</measure>
    <time_frame>Immediately following a blood draw.</time_frame>
    <description>Characterization of the performance of the FINDER G6PD assay when tested with blood from a venipuncture or arterial puncture, including umbilical catheter access, and where possible, performance will be evaluated when tested with blood from tissue puncture capillary samples.</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">119</enrollment>
  <condition>G6PD</condition>
  <condition>G6PD Deficiency</condition>
  <arm_group>
    <arm_group_label>Adult</arm_group_label>
    <description>Adults aged 18 years or older. Collect whole blood sample via venous/arterial puncture and, where possible, finger stick.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Neonate</arm_group_label>
    <description>Neonates gestational age &gt;35 weeks or older. Collect whole blood sample via heel prick or, where an in dwelling line already exists, via arterial/umbilical draw.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>G6PD assay</intervention_name>
    <description>A test for G6PD deficiency.</description>
    <arm_group_label>Adult</arm_group_label>
    <arm_group_label>Neonate</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Adults who are at least 18 years of age or older. Neonates who are at least 35 gestational&#xD;
        weeks old, recruited from the well baby nursery or the NICU.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Neonates aged &gt;35 gestational weeks or older.&#xD;
&#xD;
          -  Adult subjects who are age 18 and older.&#xD;
&#xD;
          -  Adult subjects who weigh at least 110 pounds.&#xD;
&#xD;
          -  All ethnicities.&#xD;
&#xD;
          -  Male and female subjects.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Adult subjects who weigh less than 110 pounds.&#xD;
&#xD;
          -  Subjects with anemia for which an attending physician will not authorize a blood draw.&#xD;
&#xD;
          -  Subjects who have received a blood transfusion.&#xD;
&#xD;
          -  Subjects who are pregnant.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>35 Weeks</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rama Sista, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Director Product Development</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Duke Health</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27705</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wake Med</name>
      <address>
        <city>Raleigh</city>
        <state>North Carolina</state>
        <zip>27610</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospitals Cleveland Medical Center Rainbow Children's Hospital</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44106</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>October 29, 2019</study_first_submitted>
  <study_first_submitted_qc>October 29, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 31, 2019</study_first_posted>
  <last_update_submitted>November 20, 2020</last_update_submitted>
  <last_update_submitted_qc>November 20, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 23, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>G6PD</keyword>
  <keyword>Neonate</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glucosephosphate Dehydrogenase Deficiency</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

